Connors Investor Services Inc. trimmed its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 24.5% in the 4th quarter, Holdings Channel reports. The firm owned 12,245 shares of the company’s stock after selling 3,965 shares during the period. Connors Investor Services Inc.’s holdings in Procter & Gamble were worth $1,755,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently made changes to their positions in the stock. Delta Asset Management LLC TN raised its holdings in shares of Procter & Gamble by 1.2% during the fourth quarter. Delta Asset Management LLC TN now owns 233,832 shares of the company’s stock valued at $33,510,000 after purchasing an additional 2,833 shares during the last quarter. Prospera Financial Services Inc raised its holdings in shares of Procter & Gamble by 1.3% during the fourth quarter. Prospera Financial Services Inc now owns 253,709 shares of the company’s stock valued at $36,375,000 after purchasing an additional 3,310 shares during the last quarter. Pathfinder Wealth Consulting Inc. purchased a new position in shares of Procter & Gamble during the fourth quarter valued at approximately $626,000. Carroll Advisory Group LLC bought a new stake in Procter & Gamble during the fourth quarter valued at approximately $8,106,000. Finally, Jefferies Financial Group Inc. grew its position in Procter & Gamble by 122.7% during the fourth quarter. Jefferies Financial Group Inc. now owns 997,764 shares of the company’s stock valued at $142,990,000 after buying an additional 549,724 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several analysts recently issued reports on PG shares. Rothschild & Co Redburn cut their target price on shares of Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating for the company in a research report on Monday, April 27th. UBS Group boosted their target price on shares of Procter & Gamble from $166.00 to $172.00 and gave the company a “buy” rating in a research report on Monday, April 27th. Barclays cut their target price on shares of Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Jefferies Financial Group cut their target price on shares of Procter & Gamble from $179.00 to $175.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Finally, Morgan Stanley cut their target price on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $161.06.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 5,549 shares of the company’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $165.29, for a total value of $917,194.21. Following the completion of the transaction, the chief executive officer directly owned 1,029 shares in the company, valued at $170,083.41. This represents a 84.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Stock Performance
PG opened at $144.50 on Friday. The firm has a market cap of $336.49 billion, a P/E ratio of 21.13, a PEG ratio of 6.19 and a beta of 0.41. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $170.99. The company has a 50 day simple moving average of $144.93 and a two-hundred day simple moving average of $147.95. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. The business had revenue of $21.24 billion during the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The company’s revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.54 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were given a $1.0885 dividend. The ex-dividend date was Friday, April 24th. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.06. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble’s dividend payout ratio (DPR) is currently 63.60%.
Procter & Gamble Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
